Methadone Recycling Sustains Drug Reservoir in Tissue

REFERENCES

• Atkinson TJ, Fudin J, Pandula A, Mirza M. Medication pain management in the elderly: unique and underutilized analgesic treatment options. Clin Ther. 2013;35:1669–1689.
   PubMed Web of Science ®Google Scholar
• Kreek M, Borg L, Ducat E, Ray B. Pharmacotherapy in the treatment of addiction: methadone. J Addict Dis. 2010;29:200–216.
   PubMed Web of Science ®Google Scholar
• Manfredi PL, Houde RW. Prescribing methadone, a unique analgesic. J Support Oncol. 2003;1:216–220.
   PubMedGoogle Scholar
• Mercandante S, Casuccio A, Angello A, Serretta R, Calderone L, Barresi L. Morphine versus methadone in the pain treatment of advanced cancer patients followed at home. J Clin Oncol. 1998;16:3656–3661.
   PubMed Web of Science ®Google Scholar
• Auret K, Roger Goucke C, Ilett KF, Page-Sharp M, Boyd F, Oh TE. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain. Ther Drug Monit. 2006;28:359–366.
   PubMed Web of Science ®Google Scholar
• Chhabra S, Bull J.Methadone. Am J Hosp Palliat Care. 2008;25:146–150.
   PubMed Web of Science ®Google Scholar
• Inturrisi CE, Colburn WA, Kaiko RF, Houde RW, Foley KM. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther. 1987;41:392–401.
   PubMed Web of Science ®Google Scholar
• Inturrisi CE, Portenoy RK, Max MB, Colburn WA, Foley KM. Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther. 1990;47:565–577.
   PubMed Web of Science ®Google Scholar
• Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage. 2001;22:672–687.
   PubMed Web of Science ®Google Scholar
• Fudin J, Fontenelle DV, Fudin HR, Carlyn C, Hinden DA, Ashley CC. Potential P-glycoprotein pharmacokinetic interaction of telaprevir with morphine or methadone. J Pain Palliat Care Pharmacother. 2013;27:261–267.
   PubMedGoogle Scholar
• Li L, Levine B, Smialek JE. Fatal methadone poisoning in children: Maryland 1992–1996. Subst Use Misuse. 2000;35:1141–1148.
   PubMed Web of Science ®Google Scholar
• Couper F, Chopra K, Pierre-Louis M. Fatal methadone intoxication in an infant. For Sci Int. 2005;153:71–73.
   Google Scholar
• Kuehn BM. Methadone overdose deaths rise with increased prescribing for pain. JAMA. 2012;308:749–750.
   PubMed Web of Science ®Google Scholar
• Dole VP, Kreek MJ. Methadone plasma level: sustained by a reservoir of drug in tissue. Proc Natl Acad Sci U S A. 1973;70:10.
   PubMed Web of Science ®Google Scholar
• Holford N, Ploeger BA. Clinical trial simulation: a review. Clin Pharmacol Ther. 2010;88:166–182.
   PubMed Web of Science ®Google Scholar
• Wolff K, Rostami-Hodjegan A, Shires S, et al. The pharmacokinetics of methadone in healthy subjects and opiate users. Br J Clin Pharmacol. 1997;44:325–334.
   PubMed Web of Science ®Google Scholar
• Sheiner LB, Beal SL. Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. J Pharmaceut Sci. 1982;71:1344–1348.
   PubMed Web of Science ®Google Scholar
• Ashby D. Bayesian statistics in medicine: a 25 year review. Stat Med. 2006;25:3589–3631.
   PubMed Web of Science ®Google Scholar
• Berman M, Schoenfeld R. Invariants in experimental data on linear kinetics and the formulation of models. J Appl Phys. 1956;27:1361–1370.
   Web of Science ®Google Scholar
• Landlaw EM, DiStefano JJ. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am J Physiol. 1984;246:R665–R677.
   PubMed Web of Science ®Google Scholar
• Carson ER, Cobelli C, Finkelstein L. Modeling and identification of metabolic systems. Am J Physiol Regul Integr Comp Physiol. 1981;240:R120–R129.
   PubMed Web of Science ®Google Scholar
• Linares O, Jacquez J, Zech L, et al. Norepinephrine metabolism in humans: kinetic analysis and model. J Clin Invest. 1987;80:1332–1341.
   PubMed Web of Science ®Google Scholar
• Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716–723.
   Web of Science ®Google Scholar
• Godfrey KR, Chapman MJ. The problem of model indistinguishability in pharmacokinetics. J Pharmacokinet Biopharm. 1989;17:229–267.
   PubMedGoogle Scholar
• Jacquez J, Simon C. Qualitative therory of compartmental systems. SIAM Rev. 1993;35:43–79.
   Web of Science ®Google Scholar
• Grossman P, Linares O, Supiano M, Oral H, Mehta R, Starling M. Cardiac-specific norepinephrine mass transport and its relationship to left ventricular size and systolic performance. Am J Physiol Heart Circ Physiol. 2004;287:H878–H888.
   PubMed Web of Science ®Google Scholar
• Rescigno A. Compartmental analysis an its manifold applications in pharmacokinetics. AAPS J. 2010;12:61–72.
   PubMed Web of Science ®Google Scholar
• Hearon J. Theorems on linear systems. Ann N Y Acad Sci 1963;108;36–68.
   PubMed Web of Science ®Google Scholar
• Jacquez J. Compartmental Analysis in Biology and Medicine. 3rd ed. Ann Arbor, MI: BioMedware; 1996.
   Google Scholar
• Rescigno A, Gurpide E. Estimation of average times of residence, recycle, and interconversion of blood-borne compounds using tracer methods. J Clin Endocrinol Metab. 1973;36:263–276.
   PubMed Web of Science ®Google Scholar
• Covell D, Berman M, Delisi C. Mean residence time-theoretical development, experimental determination, and practical use in tracer analysis. Math Biosci. 1984;72:213–244.
   Web of Science ®Google Scholar
• Savic RM, Jonker DM, Kerbusch T, Karlsson M. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J Pharmacokinet Pharmacodyn. 2007;34:711–726.
   PubMed Web of Science ®Google Scholar
• Jacquez JA. Identifiability: the first step in parameter estimation. Fed Proc. 1987;46:2477–2480.
   PubMedGoogle Scholar
• Wagner J. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm. 1976;4:443–467.
   PubMedGoogle Scholar
• Gurpide E, Mann J. Interpretation of isotopic data obtained from blood-borne compounds. J Clin Endocrinol Metab. 1970;30:707–718.
   PubMed Web of Science ®Google Scholar
• Cobelli C, Caumo A. Using what is accessible to measure that which is not: necessity of model of system. Metabolism. 1998;47:1009–1035.
   PubMed Web of Science ®Google Scholar
• Wastney M, Patterson B, Linares O, Greif P, Boston R. Investigating Biological Systems Using Modeling: Strategies and Software. San Diego: Academic Press; 1999.
   Google Scholar
• Gillespie WR. Noncompartmental versus compartmental modelling in clinical pharmacokinetics. Clin Pharmacokinet. 1991;20:253–262.
   PubMed Web of Science ®Google Scholar
• Caprani O, Sveinsdottir E, Lassen N. SHAM, a method for biexponential curve resolution using initial slope, height, area and moment of the experimental decay type curve. J Theor Biol. 1975;52:299–315.
   PubMed Web of Science ®Google Scholar
• Scheiner LB, Stanski DR, Voseh S, Miller RD, Ham J. Simultaneous modeling of pharmacokinetics and pharmacodynamics: applications to d-tubocurarine. Clin Pharmacol Ther. 1979;25:358–371.
   PubMed Web of Science ®Google Scholar
• Danhof M, de Jongh J, De Lange ECM, Della Pasqua O, Ploeger BA, Voskuy RA. Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis. Annu Rev Pharmacol Toxicol. 2007;47:357–400.
   PubMed Web of Science ®Google Scholar
• Lafrance P, Lemaire V, Varin F, Donati F, Belair J. Spatial effects in modeling pharmacokinetics of rapid action drugs. Bull Math Biol. 2002;64:483–500.
   PubMed Web of Science ®Google Scholar
• Greenblatt D, Koch-Weser J. Clinical pharmacokinetics (second of two parts). New Engl J Med. 1975;293:964–970.
   PubMed Web of Science ®Google Scholar
• Vergnaud JM, Rosca ID. Assessing Bioavailability of Drug Delivery Systems: Mathematical Modeling. Boca Raton, FL: CRC Taylor & Francis Group; 2005.
   Google Scholar
• Linares OA, Fudin J, Schiesser WE, Daly Linares A, Boston RC. Oxycodone recycling: a novel hypothesis of opioid tolerance development in humans. Med Hypotheses. 2014;83:326–331.
   PubMed Web of Science ®Google Scholar
• Linares OA, Schiesser WE, Daly A. Organ-specific microcirculatory mass transport of oxycodone in humans: clinical implications for therapeutic use. Clin J Pain. 2015;31:206–213.
   PubMed Web of Science ®Google Scholar
• Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robsertson AD, Mehler PS. Torsade de pointes associated with very-high dose methadone. Ann Intern Med. 2002;137:501–504.
   PubMed Web of Science ®Google Scholar
• Eap CB, Crettol S, Rougier JS, et al. Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clin Pharmacol Ther. 2007;81:719–728.
   PubMed Web of Science ®Google Scholar
• Enquist J, Ferwerda M, Milan-Lobo L, Whistler JL. Chronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice. J Pharmacol Exp Ther. 2012;340:386–392.
   PubMed Web of Science ®Google Scholar
• Pittman RN. Regulation of Tissue Oxygenation. San Rafael, CA: Morgan & Claypool Life Sciences; 2011.
   Google Scholar
• Greif P, Wastney M, Linares O, Boston R. Balancing needs, efficiency, and functionality in the provision of modeling software: a perspective of the NIH WinSAAM Project. Adv Exp Med Biol. 1998;445:3–20.
   PubMed Web of Science ®Google Scholar
• Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. SIAM J Appl Math. 1963;11: 164–168.
   Web of Science ®Google Scholar
• Wagner JG. Pharmacokinetics for the Pharmaceutical Scientist. Lancaster, PA: Technomic Publications; 1993.
   Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300.
   Web of Science ®Google Scholar
• Bangalore S, Messerli FH. Of statistical significance: “trends” toward significance and optimism bias. J Am Coll Cardiol. 2006;48:1417.
   Google Scholar
• Kopin I, Rundqvist B, Friberg P, Lenders J, Goldstein D, Eisenhofer G. Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. Am J Physiol. 1998;275:R165–R173.
   PubMed Web of Science ®Google Scholar
• Goldstein D, Katzper M, Linares O, Kopin I. Kinetic model for the fate of 6-[18F]fluorodopamine in the human heart: a novel means to examine cardiac sympathetic neuronal function. Naunyn Schmiedebergs Arch Pharmacol. 2002;365: 38–49.
   PubMed Web of Science ®Google Scholar
• Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the cirulation: source, fate, and functions. Physiol Rev 1990;70:963–985.
   PubMed Web of Science ®Google Scholar
• Linares OA, Halter JB. Sympathochromaffin system activity in the elderly. J Am Geriatr Soc. 1987;35:448–453.
   PubMed Web of Science ®Google Scholar
• Shah SD, Tse TF, Clutter WE, Cryper PE. The human sympathochromaffin system. Am J Physiol. 1984;247(3 Pt 1):E380–E384.
   PubMed Web of Science ®Google Scholar
• Oreskes N, Shrader-Frechette K, Belitz K. Verification, validation, and confirmation of numerical models in the earth sciences. Science. 1994;263:641–646.
   PubMed Web of Science ®Google Scholar